Alkem Laboratories Limited
NSE:ALKEM.NS
5,706.5 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Alkem Laboratories Limited |
Symbool | ALKEM.NS |
Munteenheid | INR |
Prijs | 5,706.5 |
Beurswaarde | 682,297,672,500 |
Dividendpercentage | 0.85% |
52-weken bereik | 4,212.5 - 6,439.9 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Basudeo Narian Singh |
Website | https://www.alkemlabs.com |
An error occurred while fetching data.
Over Alkem Laboratories Limited
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)